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What we don't know
What are the physiological and prognostic consequences of unilateral and bilateral eff usions in mechanically ventilated patients? Th ere are no established methods that assess the physiological impact of a pleural eff usion, in terms of gas exchange, pulmonary mechanics, or work of breathing, and hence that predict the potential benefi t of drainage. It can be argued that a pleural eff usion will cause some degree of local atelectasis in dependent lung parenchyma, resulting in a negative eff ect on global ventilation perfusion matching and increasing the risks of pneumonia and empyema. Additional potential sequelae include diaphragmatic dysfunction, an increase in the work of breathing, and delayed/protracted weaning from support. Accordingly, enthusiasts for an aggressive drainage management strategy claim that such an approach is safe and eff ective. However, advocates of a minimal intervention strategy are equally vociferous.
What we didn't know we knew
As a starting point in establishing some of the answers to these questions, Goligher and colleagues [1] present their systematic review and meta-analysis of available evidence in the previous issue of Critical Care. Th eir meticulous literature review reveals a surprising lack of published data (19 studies and 1,124 patients) given the very high incidence of this pathology. In particular, the authors found no controlled trials or trials that reported mean ingful clinical outcomes. What few data there are suggest an unpredictable improvement in short-term oxygena tion, the clinical consequences of which are unknown, and an apparently very low rate of signifi cant compli cations. Th e authors of one of the included studies reported that thoracocentesis 'changed the diagnosis' in 49 of 113 patients and resulted in 'a modifi cation of treatment' in 35 [2] . However, this failed to have a measurable eff ect on clinical outcome. One other study reported that thoracocentesis 'aff ected management' in 24 of 32 cases [3] . Th ere is an apparent logical disconnect between claims of such high rates of the value of thoracocentesis and the lack of meaningful eff ects. Goligher and colleagues conclude that there is no convincing evidence to support any management strategy.
How should we resolve the unknowns?
Th e management of pleural eff usions in mechanically ventilated patients can hardly be described as a headlinegrabbing topic. It is, however, a sobering example of a common intensive care unit pathology that has been neglected as a topic of informative research, and in this respect, it is not alone. Is there an argument that such topics should be propelled up the research agenda? I would argue that, yes, it is clinically and ethically vital that we get all of the common and simple things right before we succumb to the allure of complex new therapies and interventions. We should develop reliable bedside assessments of the probable functional significance of a pleural eff usion and design trials that provide answers that guide our management.
